Michigan Rx drug price web site "fails"

27 May 2007

The US state of Michigan's prescription drug pricing web site has been condemned as inadequate by the State's own Attorney General, Mike Cox (Republican), who notes the presence of massive price variations across the region for certain drugs as evidence that the information is not accessible to patients or comprehensive enough.

Among the reforms proposed by the Republican official, raising the number of prescription drug prices monitored on-line from 30 to 150-200 and making the web site more accessible. Researchers from Mr Cox' department recorded variations of over 100% in the price of some drugs in Michigan.

A spokesman for the Michigan Department of Community Health (which has a Democratic party administration) implied that there were higher priorities "like providing health care for poor people," the Detroit Free Press reported.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight